Primary graft dysfunction in lung transplantation

Seminars in Respiratory and Critical Care Medicine

Volumn 27, Issue 5, 2006, Pages 501-507

  Carter, Yvonne Marie ^a   Davis, R Duane ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allograft; Complication; Dysfunction; Lung; Transplant

Indexed keywords

GRAFT DYSFUNCTION; INNATE IMMUNITY; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SURGICAL TECHNIQUE;

GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; REPERFUSION INJURY;

EID: 33750563188     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-954608     Document Type: Review

References (52)

1. Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003;124:1232-1241
2. King RC, Binns OA, Rodriguez F, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000;69:1681-1685
3. Christie JD, Bavaria JE, Palevsky HI, et al. Primary graft failure following lung transplantation. Chest 1998;114:51-60
4. Khan SU, Salloum J, O'Donovan PB, et al. Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. Chest 1999;116:187-194
5. Thabut G, Vinatier I, Stern JB, et al. Primary graft failure following lung transplantation: predictive factors of mortality. Chest 2002;121:1876-1882
6. Hartwig MG, Davis RD. Surgical considerations in lung transplantation: transplant operation and early postoperative management. Respir Care Clin 2004;15:473-504
7. Fiser SM, Tribble CG, Long SM, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002; 73:1041-1047
8. Fisher AJ, Wardle J, Dark JH, Corris PA. Nonimmune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS). J Heart Lung Transplant 2002;21:1206-1212
9. Khan SU, Salloum J, O'Donovan PB, et al. Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. Chest 1999;116:187-194
10. Chatila WM, Furukawa S, Gaughan JP, Criner GJ. Respiratory failure after lung transplantation. Chest 2003; 123:165-173
11. Whitson BA, Nath DS, Johnson AC, et al. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 2006;131:73-83
12. Trulock EP, Edwards LB, Taylor DO, et al. The registry of the International Society for Heart and Lung Transplantation: twentieth official adult lung and heart-lung transplant report. J Heart Lung Transplant 2003;22:625-635
13. Meyers BF, de la Morena M, Sweet SC, et al. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg 2005;129:1421-1429
14. Kundu S, Herman SJ, Winton TL. Reperfusion edema after lung transplantation: radiographic manifestations. Radiology 1998;206:75-80
15. Fehrenbach H, Schepelmann D, Albes JM, et al. Pulmonary ischemia/reperfusion injury: a quantitative study of structure and function in isolated heart-lungs of the rat. Anat Rec 1999;255:84-89
16. Fiser SM, Kron IL, Long SM, et al. Influence of graft ischemic time on outcomes following lung transplantation. J Heart Lung Transplant 2001;20:1291-1296
17. King RC, Binns OA, Rodriguez F, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000;69:1681-1685
18. Egan TM, Detterbeck FC, Mill MR, et al. Long-term results of lung transplantation for cystic fibrosis. Eur J Cardiothorac Surg 2002;22:602-609
19. Schnickel GT, Ross DJ, Beygui R, et al. Modified reperfusion in clinical lung transplantation: the result of 100 consecutive cases. J Thorac Cardiovasc Surg 2006;131:218-223
20. Gammie JS, Stukus DR, Pham SM, et al. Effect of ischemic time on survival in clinical lung transplantation. Ann Thorac Surg 1999;68:2015-2020
21. Ueno T, Snell GI, William TJ, et al. Impact of graft ischemic time on outcomes after bilateral sequential single-lung transplantation. Ann Thorac Surg 1999;67:1577-1582
22. Shumway SJ, Hertz MI, Petty MG, Bolman RM III. Liberalization of donor criteria in lung and heart-lung transplantation. Ann Thorac Surg 1994;57:92-95
23. Sundaresan S, Semenkovich J, Ochoa L, et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995; 109:1075-1079
24. Sundaresan S, Trachiotis GD, Aoe M, et al. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. Ann Thorac Surg 1993;56:1409-1413
25. Straznicka M, Follette DM, Eisner MD, et al. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 2002;124:250-258
26. Pierre AF, Sekine Y, Hutcheon MA, Waddell TK, Keshavjee SH. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002;123:421-427
27. Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB. Report of the ISHLT working group on primary lung graft dysfunction, V: Predictors and outcomes. J Heart Lung Transplant 2005;24:1483-1488
28. Waddell TK, Gorczynski RM, DeCampos KN, Patterson GA, Slutsky AS. Major histocompatibility complex expression and lung ischemia-reperfusion in rats. Ann Thorac Surg 1996;62:866-872
29. de Perrot M, Sekine Y, Fisher S, et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002;165:211-215
30. Fisher AJ, Donnelly SC, Hirani N, et al. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med 2001;163:259-265
31. DiGiovine B, Lynch JP III, Martinez FJ, et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol 1996;157:4194-4202
32. Meyers BF, Sundt TM III, Henry S, et al. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg 2000;120:20-26
33. Hartwig MG, Appel JZ, Cantu E, et al. Improved results treating lung allograft failure with venovenous extracorporal membrane oxygenation. Ann Thorac Surg 2005;80:1872-1880
34. Date H, Triantafillou AN, Trulock EP, Pohl MS, Cooper JD, Patterson GA. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996;111:913-919
35. Macdonald P, Mundy J, Rogers P, et al. Successful treatment of life-threatening acute reperfusion injury after lung transplantation with inhaled nitric oxide. J Thorac Cardiovasc Surg 1995;110:861-863
36. Adatia I, Lillehia C, Arnold JH, et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994;57:1311-1318
37. Hermle G, Schutte H, Walmrath D, Geiger K, Seeger W, Grimminger F. Ventilation - perfusion mismatch after lung ischemia-reperfusion: protective effect of nitric oxide. Am J Respir Crit Care Med 1999;160:1179-1187
38. Murakami S, Bacha EA, Mazmanian GM, et al. Effects of various timing and concentrations of inhaled nitric oxide in lung ischemia-reperfusion. The Paris-Sud University Lung Transplantation Group. Am J Respir Crit Care Med 1997;156(2 Pt 1):454-458
39. Bhabra MS, Hopkinson DN, Shaw TE, Hooper TL. Low-dose nitric oxide inhalation during initial reperfusion enhances rat lung graft function. Ann Thorac Surg 1997;63:339-344
40. Bhabra MS, Hopkinson DN, Shaw TE, Hooper TL. Attenuation of lung graft reperfusion injury by a nitric oxide donor. J Thorac Cardiovasc Surg 1997;113:327-333
41. Mayer E, Puskas JD, Cardoso PFG, Shi S, Slutsky AS, Patterson GA. Reliable eighteen-hour lung preservation at 4 degree and 10 degree Celsius by pulmonary artery flush after high-dose prostaglandin El administration. J Thorac Cardiovasc Surg 1992;103:1136-1142
42. Naka Y, Roy DK, Liao H, et al. cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Insights into the mechanism of action of prostaglandin E1 to improve lung preservation. Circ Res 1996;79:773-783
43. Chiang CH, Wu K, Yu CP, Yan HC, Perng WC, Wu CP. Hypothermia and prostaglandin E1 produce synergistic attenuation of ischemia-reperfusion lung injury. Am J Respir Crit Care Med 1999;160:1319-1323
44. Ueno T, Yokomise H, Oka T, et al. The effect of PGE1 and temperature on lung function following preservation. Transplantation 1991;52:626-630
45. de Perrot M, Liu M, Jin R, Xiao-Hui B, Waddell TK, JKeshavjee S. Prostaglandin protects lung transplants from ischemia-reperfusion injury, a shift from pro- to antiinflammatory cytokines. Transplant 2001;72:1505-1512
46. Korom S, Hillinger S, Cardell M, et al. Sildenafil extends survival and graft function in a large animal lung transplant model. Eur J Cardiothorac Surg 2006;29:288-293
47. Kron IL, Tribble CG, Kern JA, et al. Successful transplantation of marginally acceptable thoracic organs. Ann Surg 1993;217:518-522
48. Bhabra MS, Hopkinson DN, Shaw TE, Onwu N, Hooper TL. Controlled reperfusion protects lung grafts during a transient early increase in permeability. Ann Thorac Surg 1998;65:187-192
49. Ng CSH, Wan S, Arifi AA, Yim APC. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today 2006;36:205-214
50. Thabut G, Brugiere O, Leseche G, et al. Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation. Transplantation 2001; 71:1295-1300
51. de Perrot M, Bonser RS, Dark J, et al. Report of the ISHLT working group on primary lung graft dysfunction, III: Donor-related risk factors and markers. J Heart Lung Transplant 2005;24:1460-1467
52. Colombat M, Castier Y, Leseche G, et al. Early expression of adhesion molecules after lung transplantation: evidence for a role of aggregated P-selectin positive platelets in human primary graft failure. J Heart Lung Transplant 2004;23:1087-1092